NEW YORK--(BUSINESS WIRE)---- $LFMD #ClassAction--Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against LifeMD, Inc. (“LifeMD” or the “Company”) (NASDAQ: LFMD) and reminds investors of the October 27, 2025 deadline to seek the role of lead plaintiff in a federal securities class action that has been filed against the Company. Faruqi & Faruqi is a leading national securities law firm with offices in New York, Pennsylvania, California and Georgia. The firm has r
Related Questions
What is the potential financial exposure for LifeMD if the class action proceeds and how might that affect the stock valuation?
How likely is it that a lead plaintiff will be appointed and what precedent does this set for similar securities litigation in the biotech sector?
What is the market's immediate reaction to the deadline reminder and can we anticipate increased volatility or short‑selling activity around the October 27, 2025 date?